Martin Stockler

Martin Stockler is Professor of Oncology and Clinical Epidemiology at The University of Sydney, with dual clinical roles as a consultant medical oncologist at Concord Repatriation General Hospital and Chris O’Brien Lifehouse RPA. He serves as Oncology Director at the NHMRC Clinical Trials Centre and has led major international clinical trials in genitourinary, gynaecologic, and thoracic cancers. His research integrates clinical epidemiology with innovative trial designs to improve patient outcomes.

• MBBS (Hons), University of Sydney
• MSc in Clinical Epidemiology, University of Toronto
• FRACP (Fellow of the Royal Australasian College of Physicians)

His research focuses on clinical trials to enhance quality of life, survival, and doctor-patient communication in cancer care. Key areas include prognostication in advanced cancer, genitourinary oncology, and evidence-based medicine. Recent work emphasizes PSMA PET imaging, lipid biomarkers, and theranostic approaches like [177Lu]Lu-PSMA-617 therapy.

Publications span topics in phase III trials (ENZAMET, OUTBACK), biomarker validation (PCPro, PSMA PET), and patient-centered outcomes. Notable contributions include systematic reviews on prognostic discussions and patient-reported outcome measures in ovarian, testicular, and gastric cancers. He has authored book chapters on cancer communication and clinical decision-making.